Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MIRA

+ Watchlist+ Portfolio

MIRA Pharmaceuticals, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.59
52-Week Range
$0.34 – $1.69
Market Cap
$15.48M
P/E (TTM)
36.83
EPS (TTM)
0.01
Dividend Yield
0.00%
Advanced Metrics
Price/Book
2.26
PEG Ratio
—
Return on Equity
-135.71%
Return on Assets
-79.66%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
16.97
Debt/Equity
0.03
Total Debt
$194.19K
Free Cash Flow
$327.72K
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$18.06M

Market Snapshot

About

MIRA Pharmaceuticals is a pre-clinical biotech company developing cannabinoid-based therapies. The company focuses on novel drug candidates for neurological disorders and other medical conditions.